       Cognition Therapeutics, Inc.  
  2500 Westchester Avenue Suite 220  
Purchase, NY 10577  
  412-481-2210  
 
 
  
 Document: Redacted Protocol  COG 0201  
 
  
Official Title:  A Randomized, Double-Blind, Placebo -
Controlled, Parallel -Group, Phase 2 Study to Evaluate the 
Safety and Efficacy of CT1812 in Subjects With Mild to 
Moderate Alzheimer's Disease.  
  
ClinicalTrials.gov ID (NCT number): [STUDY_ID_REMOVED]  
  
Protocol  Date :  Version 6.0_1 2 June 2023 
  
 